Trump Signs Order to Cut Routine Childhood Vaccines 
GLP-1 Weight-Loss Drug Use Surges Among U.S. Children 
Novo Nordisk Strikes €1.17 Billion Nanexa Drug Delivery Deal 
Senate Sets December 8 Vote on Trump’s NASA Nominee Jared Isaacman 
Asian Stocks Rise as Nasdaq Record Offsets Bond Yield Pressure 
NASA Artemis II: First Crewed Moon Mission Since Apollo Takes Four Astronauts on 10-Day Lunar Journey 
Eli Lilly Eyes AtaiBeckley Acquisition to Expand Psychedelic Mental Health Pipeline 
FDA Weighs Safety Standards for Psychedelic Therapies 
Blue Origin New Glenn Explosion Could Delay Launch Operations Until 2028 
Blue Origin’s New Glenn Achieves Breakthrough Success With First NASA Mission 
Dollar Retreats From 18-Month High as Euro Rebounds 
Japan Real Wages Rise 1.5%, Supporting BOJ Rate Hikes 
Is space worth the cost? Accounting experts say its value can’t be found in spreadsheets 
Asian Currencies Mixed as Yen Weakens, Dollar Holds Firm 
Novartis Shares Plunge After Muscle Drug Fails Phase III Trial 
AstraZeneca, Bristol Myers Squibb Explore Mega Merger Worth Nearly $400 Billion 
Add as a preferred source on Google
A new diagnostic method that ascertains if a person is suffering from Parkinson’s disease or dementia by looking at the manner of walking has been patented.
A new diagnostic technique developed by a St. Mary's Hospital research team in Uijeongbu has been patented and put up for patent registration, which analyses data from an individual's shoes to detect neurological disorders.
Most degenerative brain disorders, such as Parkinson's disease, dementia, and Lou Gehrig's disease, occur at an older age.
Currently, a costly MRI or a PET scan is required for such diagnosis, as well as frequent visits to the hospital.
The new approach, on the other hand, employs a "smart insole" that is placed inside a shoe and collects data from its sensors, which is then analyzed to assess the brain health of the wearer.
The new technique achieved an accuracy of 98.1 percent for the diagnosis of Parkinson's disease, as well as 83.2 percent for differentiating whether an illness is vascular or degenerative.
